Open AccessDiagnosis and treatment of gastrointestinal stromal tumor extending to prostate
Author(s) -
Huan Xu,
Chong Liu,
Yanbo Chen,
Meng Gu,
Zhixiang Cai,
Qi Chen,
Zhong Wang
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000005439
Subject(s) - medicine , gist , stromal tumor , prostate , imatinib , gastrointestinal tract , prostatectomy , metastasis , stromal cell , imatinib mesylate , oncology , urology , cancer , myeloid leukemia
Rationale: Gastrointestinal stromal tumor (GIST) is the neoplasm of gastrointestinal tract. Patient concerns: The patient complained about the retention of urinary. Diagnoses: GIST. Interventions: radical prostatectomy and the imatinib therapy. Outcomes: No recurrence and metastasis have been found during a 14-month follow-up. Lessons: comprehensive treatment is necessary for the GIST treatment. Furthermore, we summarize a review of the literature of GIST occurring in the prostate gland treated by different methods and 4 kinds of rare diseases in prostate.